Asialoerythropoietin prevents contrast-induced nephropathy

Journal of the American Society of Nephrology

Volumn 19, Issue 2, 2008, Pages 321-328

  Yokomaku, Yukiyo ^a   Sugimoto, Toshiro ^a   Kume, Shinji ^a   Araki, Shin Ichi ^a   Isshiki, Keiji ^a   Chin Kanasaki, Masami ^a   Sakaguchi, Masayoshi ^a   Nitta, Norihisa ^a   Haneda, Masakazu ^b   Koya, Daisuke ^c   Uzu, Takashi ^a   Kashiwagi, Atsunori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOERYTHROPOIETIN; CONTRAST MEDIUM; ERYTHROPOIETIN; HEAT SHOCK PROTEIN 70; IOVERSOL; JANUS KINASE 2; JANUS KINASE 2 INHIBITOR; NITRIC OXIDE; PROSTAGLANDIN; PROTEIN KINASE INHIBITOR; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED NEPHROPATHY; DRUG INHIBITION; ENZYME INACTIVATION; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE;

EID: 39049121208     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007040481     Document Type: Article

References (43)

1. Finn WF: The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant 21: i2-i10, 2006
2. Tepel M, Aspelin P, Lameire N: Contrast-induced nephropathy: A clinical and evidence-based approach. Circulation 113: 1799-1806, 2006
3. Mehran R, Nikolsky E: Contrast-induced nephropathy: Definition, epidemiology, and patients at risk. Kidney Int Suppl 11-15, 2006
4. Goldenberg I, Matetzky S: Nephropathy induced by contrast media: Pathogenesis, risk factors and preventive strategies. CMAJ 172: 1461-1471, 2005
5. Briguori C, Marenzi G: Contrast-induced nephropathy: Pharmacological prophylaxis. Kidney Int Suppl 30-38, 2006
6. Katzberg RW, Haller C: Contrast-induced nephrotoxicity: Clinical landscape. Kidney Int Suppl 3-7, 2006
7. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930-936, 2002
8. Humphries JE: Anemia of renal failure: Use of erythropoietin. Med Clin North Am 76: 711-725, 1992
9. Bartesaghi S, Marinovich M, Corsini E, Galli CL, Viviani B: Erythropoietin: A novel neuroprotective cytokine. Neurotoxicology 26: 923-928, 2005
10. Chong ZZ, Kang JQ, Maiese K: Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106: 2973-2979, 2002
11. Ammarguellat F, Gogusev J, Drueke TB: Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor. Nephrol Dial Transplant 11: 687-692, 1996
12. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL: Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108: 79-85, 2003
13. Westenfelder C, Biddle DL, Baranowski RL: Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 55: 808-820, 1999
14. Ribatti D, Vacca A, Roccaro AM, Crivellato E, Presta M: Erythropoietin as an angiogenic factor. Eur J Clin Invest 33: 891-896, 2003
15. Bogoyevitch MA: An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc Res 63: 208-216, 2004
16. Ghezzi P, Brines M: Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 11[Suppl 1]: 37-44, 2004
17. Maiese K, Li F, Chong ZZ: New avenues of exploration for erythropoietin. JAMA 293: 90-95, 2005
18. Rossert J, Eckardt KU: Erythropoietin receptors: Their role beyond erythropoiesis. Nephrol Dial Transplant 20: 1025-1028, 2005
19. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15: 2115-2124, 2004
20. Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW, Sun BK, Kim YS, Kim J, Chang YS, Bang BK: Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 17: 1754-1755, 2003
21. Bagnis C, Beaufils H, Jacquiaud C, Adabra Y, Jouanneau C, Le Nahour G, Jaudon MC, Bourbouze R, Jacobs C, Deray G: Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 16: 932-938, 2001
22. Goldfarb M, Rosenberger C, Ahuva S, Rosen S, Heyman SN: A role for erythropoietin in the attenuation of radiocontrast-induced acute renal failure in rats. Ren Fail 28: 345-350, 2006
23. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242, 2004
24. Imai N, Higuchi M, Kawamura A, Tomonoh K, Oh-Eda M, Fujiwara M, Shimonaka Y, Ochi N: Physicochemical and biological characterization of asialoerythropoietin. Suppressive effects of sialic acid in the expression of biological activity of human erythropoietin in vitro. Eur J Biochem 194: 457-462, 1990
25. Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M, Torup L, Sager T, Erbayraktar Z, Gokmen N, Yilmaz O, Ghezzi P, Villa P, Fratelli M, Casagrande S, Leist M, Helboe L, Gerwein J, Christensen S, Geist MA, Pedersen LO, Cerami-Hand C, Wuerth JP, Cerami A, Brines M: Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA 100: 6741-6746, 2003
26. Wang X, Zhu C, Wang X, Gerwien JG, Schrattenholz A, Sandberg M, Leist M, Blomgren K: The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J Neurochem 91: 900-910, 2004
27. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M: Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94: 1069-1075, 1994
28. Heyman SN, Fuchs S, Jaffe R, Shina A, Ellezian L, Brezis M, Rosen S: Renal microcirculation and tissue damage during acute ureteral obstruction in the rat: Effect of saline infusion, indomethacin and radiocontrast. Kidney Int 51: 653-663, 1997
29. Hardiek K, Katholi RE, Ramkumar V, Deitrick C: Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol 280: F61-F70, 2001
30. Ueda J, Nygren A, Sjoquist M, Jacobsson E, Ulfendahl HR, Araki Y: Iodine concentrations in the rat kidney measured by X-ray microanalysis: Comparison of concentrations and viscosities in the proximal tubules and renal pelvis after intravenous injections of contrast media. Acta Radiol 39: 90-95, 1998
31. Beaufils H, Idee JM, Berthommier C, Balut C, Bourbouze R, Nimier K, Chicandre-Jouanneau C, Bonnemain B: lobitridol, a new nonionic low-osmolality contrast agent, and iohexol: Impact on renal histology in the rat. Invest Radiol 30: 33-39, 1995
32. Tervahartiala P, Kivisaari L, Kivisaari R, Vehmas T, Virtanen I: Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Nephron 76: 96-102, 1997
33. Yano T, Itoh Y, Sendo T, Kubota T, Oishi R: Cyclic AMP reverses radiocontrast media-induced apoptosis in LLC-PK1 cells by activating A kinase/PI3 kinase. Kidney Int 64: 2052-2063, 2003
34. Chen SC, Guh JY, Chen HC, Yang YL, Huang JS, Chuang LY: Advanced glycation end-product-induced mitogenesis is dependent on Janus kinase 2-induced heat shock protein 70 in normal rat kidney interstitial fibroblast cells. Transl Res 149: 274-281, 2007
35. Madamanchi NR, Li S, Patterson C, Runge MS: Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler Thromb Vasc Biol 21: 321-326, 2001
36. Suzuki S, Maruyama S, Sato W, Morita Y, Sato F, Miki Y, Kato S, Katsuno M, Sobue G, Yuzawa Y, Matsuo S: Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int 67: 2210-2220, 2005
37. Jo SK, Ko GJ, Boo CS, Cho WY, Kim HK: Heat preconditioning attenuates renal injury in ischemic ARF in rats: role of heat-shock protein 70 on NF-kappaB-mediated inflammation and on tubular cell injury. J Am Soc Nephrol 17: 3082-3092, 2006
38. Healy DA, Daly PJ, Docherty NG, Murphy M, Fitzpatrick JM, Watson RW: Heat shock-induced protection of renal proximal tubular epithelial cells from cold storage and rewarming injury. J Am Soc Nephrol 17: 805-812, 2006
39. Gennari A, Cortese E, Boveri M, Casado J, Prieto P: Sensitive endpoints for evaluating cadmium-induced acute toxicity in LLC-PK1 cells. Toxicology 183: 211-220, 2003
40. Xu B, Dong GH, Liu H, Wang YQ, Wu HW, Jing H: Recombinant human erythropoietin pretreatment attenuates myocardial infarct size: A possible mechanism involves heat shock protein 70 and attenuation of nuclear factor-kappaB. Ann Clin Lab Sci 35: 161-168, 2005
41. Coleman TR, Westenfelder C, Togel FE, Yang Y, Hu Z, Swenson L, Leuvenink HG, Ploeg RJ, d'Uscio LV, Katusic ZS, Ghezzi P, Zanetti A, Kaushansky K, Fox NE, Cerami A, Brines M: Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci USA 103:5965-5970, 2006
42. Tanaka T, Kojima I, Ohse T, Ingelfinger JR, Adler S, Fujita T, Nangaku M: Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest 85: 1292-1307, 2005
43. Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isono M, Isshiki K, Uzu T, Kashiwagi A, Koya D: Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic Biol Med 40: 2175-2182, 2006